Division of Translational Cancer Research
1 – 10 of 574
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Therapeutic potential of miR-379 in prostate cancer
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
(
- Contribution to journal › Article
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
(
- Contribution to journal › Article
-
Mark
From master’s thesis to research publication : a mixed-methods study of medical student publishing and experiences with the publishing process
(
- Contribution to journal › Article
-
Mark
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
2024) In Histopathology(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
2024) In Oncogene(
- Contribution to journal › Article
-
Mark
AlphaML : A clear, legible, explainable, transparent, and elucidative binary classification platform for tabular data
(
- Contribution to journal › Article
-
Mark
PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation
(
- Contribution to journal › Article
-
Mark
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
(
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress
(
- Contribution to journal › Letter